Europe Opioids Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Europe Opioids Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Europe Opioids Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Europe Opioids Market Regional Analysis

6.2 Europe Opioids Market Revenue 2020-2030 (US$ Million)

6.3 Europe Opioids Market Forecast Analysis

7. Europe Opioids Market Analysis – by Product

7.1 Immediate Release Short Acting Opioid

7.1.1 Overview
7.1.2 Immediate Release Short Acting Opioid: Europe Opioids Market – Revenue and Forecast, 2020-2030 (US$ Million)

7.2 Extended Release Long Acting Opioid

7.2.1 Overview
7.2.2 Extended Release Long Acting Opioid: Europe Opioids Market – Revenue and Forecast, 2020-2030 (US$ Million)

8. Europe Opioids Market Analysis – by Application

8.1 Pain Management

8.1.1 Overview
8.1.2 Pain Management: Europe Opioids Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.2 Anesthesia

8.2.1 Overview
8.2.2 Anesthesia: Europe Opioids Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.3 Diarrhea Suppression

8.3.1 Overview
8.3.2 Diarrhea Suppression: Europe Opioids Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.4 Cough Suppression

8.4.1 Overview
8.4.2 Cough Suppression: Europe Opioids Market – Revenue and Forecast, 2020-2030 (US$ Million)

8.5 De-Addiction

8.5.1 Overview
8.5.2 De-Addiction: Europe Opioids Market – Revenue and Forecast, 2020-2030 (US$ Million)

9. Europe Opioids Market Analysis – by Route of Administration

9.1 Oral

9.1.1 Overview
9.1.2 Oral: Europe Opioids Market – Revenue and Forecast, 2020-2030 (US$ Million)

9.2 Injectable

9.2.1 Overview
9.2.2 Injectable: Europe Opioids Market – Revenue and Forecast, 2020-2030 (US$ Million)

9.3 Transdermal Patch

9.3.1 Overview
9.3.2 Transdermal Patch: Europe Opioids Market – Revenue and Forecast, 2020-2030 (US$ Million)

10. Europe Opioids Market Analysis – by Distribution Channel

10.1 Hospital Pharmacies

10.1.1 Overview
10.1.2 Hospital Pharmacies: Europe Opioids Market – Revenue and Forecast, 2020-2030 (US$ Million)

10.2 Retail Pharmacies

10.2.1 Overview
10.2.2 Retail Pharmacies: Europe Opioids Market – Revenue and Forecast, 2020-2030 (US$ Million)

11. Europe Opioids Market – Europe Analysis

11.1 Overview

11.2 Europe

11.2.1 Europe Opioids Market Breakdown, by Key Country, 2023 and 2030 (%)
11.2.1.1 Europe Opioids Market – Revenue and Forecast Analysis – by Country
11.2.1.1 UK: Europe Opioids Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.1.1 UK: Europe Opioids Market Breakdown, by Product
11.2.1.1.2 UK: Europe Opioids Market Breakdown, by Application
11.2.1.1.3 UK: Europe Opioids Market Breakdown, by Route of Administration
11.2.1.1.4 UK: Europe Opioids Market Breakdown, by Distribution Channel

11.2.1.2 Germany: Europe Opioids Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.2.1 Germany: Europe Opioids Market Breakdown, by Product
11.2.1.2.2 Germany: Europe Opioids Market Breakdown, by Application
11.2.1.2.3 Germany: Europe Opioids Market Breakdown, by Route of Administration
11.2.1.2.4 Germany: Europe Opioids Market Breakdown, by Distribution Channel

11.2.1.3 France: Europe Opioids Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.3.1 France: Europe Opioids Market Breakdown, by Product
11.2.1.3.2 France: Europe Opioids Market Breakdown, by Application
11.2.1.3.3 France: Europe Opioids Market Breakdown, by Route of Administration
11.2.1.3.4 France: Europe Opioids Market Breakdown, by Distribution Channel

11.2.1.4 Russia: Europe Opioids Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.4.1 Russia: Europe Opioids Market Breakdown, by Product
11.2.1.4.2 Russia: Europe Opioids Market Breakdown, by Application
11.2.1.4.3 Russia: Europe Opioids Market Breakdown, by Route of Administration
11.2.1.4.4 Russia: Europe Opioids Market Breakdown, by Distribution Channel

11.2.1.5 Italy: Europe Opioids Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.5.1 Italy: Europe Opioids Market Breakdown, by Product
11.2.1.5.2 Italy: Europe Opioids Market Breakdown, by Application
11.2.1.5.3 Italy: Europe Opioids Market Breakdown, by Route of Administration
11.2.1.5.4 Italy: Europe Opioids Market Breakdown, by Distribution Channel

11.2.1.6 Rest of Europe: Europe Opioids Market – Revenue and Forecast to 2030 (US$ Million)

11.2.1.6.1 Rest of Europe: Europe Opioids Market Breakdown, by Product
11.2.1.6.2 Rest of Europe: Europe Opioids Market Breakdown, by Application
11.2.1.6.3 Rest of Europe: Europe Opioids Market Breakdown, by Route of Administration
11.2.1.6.4 Rest of Europe: Europe Opioids Market Breakdown, by Distribution Channel

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Endo International plc

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 Mallinckrodt Plc

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 Neuraxpharm Pharmaceuticals SL

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Hikma Pharmaceuticals Plc

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 Rusan Pharma Ltd

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 Teva Pharmaceutical Industries Ltd

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

Europe Opioids Market